Model N Announces New Chief Financial Officer
SAN MATEO, Calif.--(BUSINESS WIRE)--$modeln--Model N, Inc. (NYSE: MODN), the leader in cloud revenue management solutions, today announced that John Ederer...
Day: December 29, 2020
Hepion Pharmaceuticals Announces Positive Top Line Data for Low Dose CRV431 in Phase 2a ‘AMBITION’ Clinical Trial for Treatment of Advanced NASH
CRV431 Demonstrated to be Generally Safe and Well Tolerated Clinically Significant Reductions in Important Biomarkers, ALT and AST, Observed in...
Dynatronics Corporation Announces R.J. Smith As Vice President of Customer Experience
Former Breg Leader To Advance Dynatronics' Business Growth EAGAN, MN / ACCESSWIRE / December 29, 2020 / Dynatronics Corporation (NASDAQ:DYNT),...
CYduct Diagnostics, Inc. Announces OTC Ticker Symbol Change to “CYDX”
WESTPORT, CT / ACCESSWIRE / December 29, 2020 / CYduct Diagnostics, Inc. (OTC PINK:SNDYD) is pleased to announce that FINRA...
CLS Holdings USA, Inc. 2020 Year in Review
LAS VEGAS, NV / ACCESSWIRE / December 29, 2020 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH): Adaptation 2020 has been a...
Hepion Pharmaceuticals Data Safety Monitoring Board Recommends Continuation with Final Dose Cohort in Phase 2a ‘AMBITION’ Clinical Trial for Treatment of Advanced NASH
- DSMB Review After Completion of the First Dose Cohort Affirmed No Safety or Tolerability Concerns with CRV431 in NASH...
IMC Says There is Still Time for Federal Government to Put Canadian Patients First by Delaying January 1, 2021 Implementation of PMPRB’s Regulations and Guidelines
OTTAWA, ON / ACCESSWIRE / December 29, 2020 / Innovative Medicines Canada (IMC) issued the following statement today regarding the...
Arch Biopartners Closes Non-Brokered Private Placement
TORONTO, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF),...
OrthoPediatrics Corp. Announces First PNP|FEMUR Case Performed in the United Kingdom
WARSAW, Ind., Dec. 29, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the...
TRACON Pharmaceuticals Announces $5.0 Million Registered Direct Offering
SAN DIEGO, Dec. 29, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...
Intra-Cellular Therapies Announces the Initiation of Clinical Trials for ITI-LLAI, a Long-Acting Injectable Formulation of Lumateperone for the Treatment of Schizophrenia and for ITI-333, a Novel Treatment for Opioid Use Disorder
The Company continues expansion of its lumateperone programs with the advancement of a Long-Acting injectable formulation into clinical trials. ITI-333...
Fulgent Genetics Extends Partnership with New York City Test and Trace for COVID-19 Testing, Awarded Contract for 2021 School Year
Following a competitive process, Fulgent was selected to extend its support of the NYC DOE public school testing managed by...
BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021
NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused...
Nova Leap Health Corp. Completes Purchase of Ohio Home Care Business
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Dec. 29, 2020...
Tabula Rasa HealthCare to Participate in Upcoming J.P. Morgan Investor Conference
MOORESTOWN, N.J., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), today announced CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.;...
Pluristem Enters Collaboration With Pharmaceutical Company Innovare R&D to Expand Pluristem’s ARDS Associated With COVID-19 Program to Mexico
HAIFA, Israel, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a...
VBL Therapeutics Announces First Patient in Europe in the OVAL Trial
Expands OVAL Phase 3 Potential Registration Study of VB-111 for the Treatment of Platinum-Resistant Ovarian Cancer into Europe TEL AVIV, Israel, Dec....
XORTX Announces Grant of European Patent
● Patent supporting Autosomal Dominant PolycysticKidney Disease Granted – XRx-008 Program ● CALGARY, Alberta, Dec. 29, 2020 (GLOBE NEWSWIRE) --...
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS
LA JOLLA, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
Novo Nordisk files for EU regulatory approval of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes
Bagsværd, Denmark, 29 December 2020 – Novo Nordisk today announced the submission of a label extension application to the European...